Tinidazole

CLINICAL USE

Antibacterial agent

DOSE IN NORMAL RENAL FUNCTION

1–2 g daily

PHARMACOKINETICS

Molecular weight : 247.3

%Protein binding : 8–121

%Excreted unchanged in urine : 20–25

Volume of distribution (L/kg) : 0.61–0.671

half-life – normal/ESRD (hrs) : 12–14/Unchanged

DOSE IN RENAL IMPAIRMENT

GFR (mL/MIN)

20 to 50 : Dose as in normal renal function

10 to 20 : Dose as in normal renal function

<10 : Dose as in normal renal function

DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

CAPD : Unknown dialysability, but likely to be dialysed. Dose as in normal renal function

HD : Dialysed. Dose as in normal renal function

HDF/high flux : Dialysed. Dose as in normal renal function

CAV/VVHD : Unknown dialysability. Dose as in normal renal function

IMPORTANT DRUG INTERACTIONS

Potentially hazardous interactions with other drugs

Alcohol: disulfiram-like reaction

ADMINISTRATION

Reconstition

–

Route

Oral

Rate of Administration

–

Comments

–

OTHER INFORMATION

Dosage adjustment in renal failure is not necessary as a decrease in renal clearance is compensated for by increased faecal excretion of tinidazole 43% can be removed during a 6 hour haemodialysis session. .

See how to identify renal failure stages according to GFR calculation

See how to diagnose irreversible renal disease

Home